Anavex Life Sciences Corp (AVXL)

[tredenwater2]

Perhaps its due to the fact that over half maybe as much as 2/3 of patients on OLE are in Australia. I wouldnt put it past DrM to run a Ph 2/3 PD/PDD in AU. Why not? Shake it up is “down under”, they are organised, and the tax credit! Perhaps they follow the Alzheimer’s model and start off with enrolling half the Ph 2/3 Parkinsons and then “globetrot” from there.

Speaking of globe trotting, if the second Parkinsons trial is a PDD, can they use the same enrolment sites that they currently have set up for the Alzheimer’s trials for recruitment? Now that would be an expedited bonus!

Just some random thoughts.

Cheers